Atıf İçin Kopyala
TOMBAK A., Ucar M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN F., AKAY O. M., ...Daha Fazla
TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.4, ss.273-280, 2016 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
33
Sayı:
4
-
Basım Tarihi:
2016
-
Doi Numarası:
10.4274/tjh.2015.0203
-
Dergi Adı:
TURKISH JOURNAL OF HEMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.273-280
-
Anahtar Kelimeler:
Azacitidine, Acute myeloid leukemia, Elderly, Bone marrow blasts, Prognostic factors, Overall survival, CONVENTIONAL CARE REGIMENS, INTERNATIONAL WORKING GROUP, ACUTE MYELOGENOUS LEUKEMIA, NEWLY-DIAGNOSED AML, OLDER PATIENTS, INTENSIVE CHEMOTHERAPY, MYELODYSPLASTIC SYNDROME, RESPONSE CRITERIA, AGE, CYTARABINE
-
İnönü Üniversitesi Adresli:
Evet
Özet
Objective: In this study, we aimed to investigate the efficacy and safety of azacitidine (AZA) in elderly patients with acute myeloid leukemia (AML), including patients with >30% bone marrow (BM) blasts.